SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-22-035188
Filing Date
2022-06-27
Accepted
2022-06-27 16:05:10
Documents
3
Group Members
ALVOGEN LUX HOLDINGS S.A R.L.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea162062-13dceltic_alvotech.htm SC 13D 76603
2 INVESTOR RIGHTS AND LOCK-UP AGREEMENT, DATED AS OF JUNE 15, 2022, BY AND AMONG T ea162062ex4_alvotech.htm EX-4 152866
3 JOINT FILING AGREEMENT ea162062ex5_alvotech.htm EX-5 10111
  Complete submission text file 0001213900-22-035188.txt   241164
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Subject) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93700 | Film No.: 221044543
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20, AVENUE MONTEREY LUXEMBOURG N4 L-2163
Business Address 20, AVENUE MONTEREY LUXEMBOURG N4 L-2163 01135220880825
Celtic Holdings SCA (Filed by) CIK: 0001935390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D